Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/41901
Title: | Long-term outcome after upgrade to cardiac resynchronization therapy: A propensity score-matched analysis | Authors: | Trenson, Sander Voros, Gabor MARTENS, Pieter Ingelaere, Sebastian Betschart, Pascal Voigt, Jens-Uwe DUPONT, Matthias Breitenstein, Alexander Steffel, Jan Willems , Rik Ruschitzka, Frank MULLENS, Wilfried Winnik, Stephan Vandenberk, Bert |
Issue Date: | 2023 | Publisher: | WILEY | Source: | EUROPEAN JOURNAL OF HEART FAILURE, | Status: | Early view | Abstract: | Aim: Cardiac resynchronization therapy (CRT) is a cornerstone in the management of chronic heart failure in patients with a broad or paced QRS. However, data on long-term outcome after upgrade to CRT are scarce.Methods and results: This international, multicentre retrospective registry included 2275 patients who underwent a de novo or upgrade CRT implantation with a mean follow-up of 3.6 +/- 2.7 years. The primary composite endpoint included all-cause mortality, heart transplantation, or ventricular assist device implantation. The secondary endpoint was first heart failure admission. Multivariable Cox regression and propensity score matching (PSM) analyses were performed. Patients who underwent CRT upgrade (n = 605, 26.6%) were less likely female (19.7% vs. 28.8%, p < 0.001), more often had ischeemic cardiomyopathy (49.8% vs. 40.2%, p < 0.001), and had worse renal function (median estimated glomerular filtration rate 50.3 ml/min/1.73 m(2) [35.8-69.5] vs. 59.9 ml/min/1.73 m(2) [43.0-76.5], p < 0.001). The incidence rate of the composite endpoint was 10.8%/year after CRT upgrade versus 7.1%/year for de novo implantations (p < 0.001). PSM for the primary endpoint resulted in 488 pairs. After propensity score matching, upgrade to CRT was associated with a higher chance to reach the composite endpoint (multivariable hazard ratio [HR] 1.35, 95% confidence interval [CI] 1.08-1.70), for both upgrade from pacemaker (multivariable HR 1.33, 95% CI 1.03-1.70) and implantable cardioverter-defibrillator (ICD) (multivariable HR 1.40, 95% CI 1.01-1.95). PSM for the secondary endpoint resulted in 277 pairs. After PSM, upgrade to CRT was associated with a higher chance for heart failure admission (HR 1.74, 95% CI 1.26-2.41).Conclusion: In this retrospective analysis, the outcome of patients who underwent upgrades to CRT differed significantly from patients who underwent de novo CRT implantation, particularly for upgrades from ICD. Importantly, this difference in outcome does not imply a causal relation between therapy and outcome but rather a difference between two different patient populations. | Notes: | Vandenberk, B (corresponding author), Katholieke Univ Leuven, Dept Cardiovasc Sci, Herestr 49, B-3000 Leuven, Belgium. vandenberkbert@gmail.com |
Keywords: | Cardiac resynchronization therapy;Upgrade;Heart failure;Pacemaker;Implantable cardioverter-defibrillator | Document URI: | http://hdl.handle.net/1942/41901 | ISSN: | 1388-9842 | e-ISSN: | 1879-0844 | DOI: | 10.1002/ejhf.3073 | ISI #: | 001103106000001 | Rights: | 2023 European Society of Cardiology | Category: | A1 | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
European J of Heart Fail - 2023 - Trenson - Long‐term outcome after upgrade to cardiac resynchronization therapy A.pdf Restricted Access | Early view | 1.05 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.